Pharming Group Nv Stock Analysis

Pharming Pink Sheet Analysis Notes

About 16.0% of the company shares are owned by institutional investors. The book value of Pharming Group was at this time reported as 0.3. The company had not issued any dividends in recent years. Pharming Group NV had 1:10 split on the 5th of March 2013. Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. Pharming Group N.V. is headquartered in Leiden, the Netherlands. Pharming Grp operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 277 people.The quote for Pharming Group NV is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Pharming Group NV contact MBA MD at 31 71 524 7400 or learn more at https://www.pharming.com.

Pharming Group NV Investment Alerts

Pharming Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 880.76 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pharming Group's market, we take the total number of its shares issued and multiply it by Pharming Group's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Pharming Profitablity

The company has Profit Margin (PM) of 0.15 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.18 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.18.

Technical Drivers

As of the 27th of November, Pharming Group holds the Variance of 5.2, coefficient of variation of (1,777), and Risk Adjusted Performance of (0.04). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pharming Group, as well as the relationship between them. Please check Pharming Group NV market risk adjusted performance, variance, as well as the relationship between the Variance and skewness to decide if Pharming Group NV is priced some-what accurately, providing market reflects its current price of 0.75 per share. As Pharming Group NV is a penny stock we also suggest to check out its information ratio numbers.

Pharming Group NV Price Movement Analysis

Pharming Group Predictive Daily Indicators

Pharming Group Forecast Models

Pharming Group's time-series forecasting models are one of many Pharming Group's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Pharming Group's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Pharming Group prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Pharming shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Pharming Group. By using and applying Pharming Pink Sheet analysis, traders can create a robust methodology for identifying Pharming entry and exit points for their positions.

When running Pharming Group's price analysis, check to measure Pharming Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharming Group is operating at the current time. Most of Pharming Group's value examination focuses on studying past and present price action to predict the probability of Pharming Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharming Group's price. Additionally, you may evaluate how the addition of Pharming Group to your portfolios can decrease your overall portfolio volatility.